Envoy Medical COCH
NASDAQ COCH
$0.75 0.00 (-0.05%)
As of: Aug 21, 2026 · 3:49 PM EDT

Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025)

Envoy Medical (COCH) posted Amortization of Deferred Charges of $4000.0 for Q4 2025, down 99.15% sequentially from $468000.0 in Q3 2025, and down 98.96% YoY from $384000.0 in Q4 2024.

Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Envoy Medical has reported Amortization of Deferred Charges for 2 years, with the latest figure at $4000.0 in Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 98.96% year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, up 94.85% from the prior year.
  • Amortization of Deferred Charges fell to $4000.0 in Q4 2025 per COCH's latest filing, from $468000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $623000.0 in Q2 2025 and troughed at $4000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Envoy Medical 77.69 Mn 58.01 Mn -227,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 468,000.00
Sep 30, 2025 468,000.00
Jun 30, 2025 623,000.00
Jun 30, 2025 623,000.00
Mar 31, 2025 495,000.00
Mar 31, 2025 495,000.00
Dec 31, 2024 384,000.00
Dec 31, 2024 384,000.00
Sep 30, 2024 264,000.00
Sep 30, 2024 264,000.00